Barbara Albrecht‐Küpper

939 total citations
14 papers, 764 citations indexed

About

Barbara Albrecht‐Küpper is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Barbara Albrecht‐Küpper has authored 14 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Physiology. Recurrent topics in Barbara Albrecht‐Küpper's work include Adenosine and Purinergic Signaling (5 papers), Cardiac Ischemia and Reperfusion (4 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Barbara Albrecht‐Küpper is often cited by papers focused on Adenosine and Purinergic Signaling (5 papers), Cardiac Ischemia and Reperfusion (4 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Barbara Albrecht‐Küpper collaborates with scholars based in Germany, United States and Netherlands. Barbara Albrecht‐Küpper's co-authors include Peter G. Nell, Stefan Schäfer, Martina Delbeck, Frank Eitner, Peter Kolkhof, Lars Bärfacker, Axel Kretschmer, Wolfram Steinke, Elke Hartmann and Kirsten Leineweber and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Kidney International.

In The Last Decade

Barbara Albrecht‐Küpper

14 papers receiving 760 citations

Peers

Barbara Albrecht‐Küpper
Curtis K. Kost United States
Barbara Albrecht‐Küpper
Citations per year, relative to Barbara Albrecht‐Küpper Barbara Albrecht‐Küpper (= 1×) peers Curtis K. Kost

Countries citing papers authored by Barbara Albrecht‐Küpper

Since Specialization
Citations

This map shows the geographic impact of Barbara Albrecht‐Küpper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Albrecht‐Küpper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Albrecht‐Küpper more than expected).

Fields of papers citing papers by Barbara Albrecht‐Küpper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Albrecht‐Küpper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Albrecht‐Küpper. The network helps show where Barbara Albrecht‐Küpper may publish in the future.

Co-authorship network of co-authors of Barbara Albrecht‐Küpper

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Albrecht‐Küpper. A scholar is included among the top collaborators of Barbara Albrecht‐Küpper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Albrecht‐Küpper. Barbara Albrecht‐Küpper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Meier, Heinrich, Alexander Straub, Joachim Mittendorf, et al.. (2024). Discovery and Preclinical Characterization of Fulacimstat (BAY 1142524), a Potent and Selective Chymase Inhibitor As a New Profibrinolytic Approach for Safe Thrombus Resolution. Journal of Medicinal Chemistry. 68(6). 6108–6126. 1 indexed citations
2.
Meibom, Daniel, Barbara Albrecht‐Küpper, Nicole Diedrichs, et al.. (2017). Neladenoson Bialanate Hydrochloride: A Prodrug of a Partial Adenosine A1 Receptor Agonist for the Chronic Treatment of Heart Diseases. ChemMedChem. 12(10). 728–737. 39 indexed citations
3.
Dinh, Wilfried, et al.. (2016). Partial Adenosine A1 Agonist in Heart Failure. Handbook of experimental pharmacology. 243. 177–203. 28 indexed citations
4.
Greene, Stephen J., Hani N. Sabbah, Javed Butler, et al.. (2015). Partial adenosine A1 receptor agonism: a potential new therapeutic strategy for heart failure. Heart Failure Reviews. 21(1). 95–102. 48 indexed citations
5.
Kolkhof, Peter, Martina Delbeck, Axel Kretschmer, et al.. (2014). Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury. Journal of Cardiovascular Pharmacology. 64(1). 69–78. 300 indexed citations
7.
Albrecht‐Küpper, Barbara, et al.. (2013). Adenylyl cyclase regulation in heart failure due to myocardial infarction in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 387(4). 389–398. 4 indexed citations
8.
Sabbah, Hani N., Ramesh C. Gupta, Smita Kohli, et al.. (2013). Chronic Therapy With a Partial Adenosine A1-Receptor Agonist Improves Left Ventricular Function and Remodeling in Dogs With Advanced Heart Failure. Circulation Heart Failure. 6(3). 563–571. 56 indexed citations
9.
Kararigas, Georgios, Virginie Bito, Hanna Tinel, et al.. (2012). Transcriptome Characterization of Estrogen-Treated Human Myocardium Identifies Myosin Regulatory Light Chain Interacting Protein as a Sex-Specific Element Influencing Contractile Function. Journal of the American College of Cardiology. 59(4). 410–417. 90 indexed citations
10.
Vignon‐Zellweger, Nicolas, Katharina Relle, Markus Alter, et al.. (2011). Endothelin-1 overexpression restores diastolic function in eNOS knockout mice. Journal of Hypertension. 29(5). 961–970. 26 indexed citations
11.
Bott‐Flügel, Lorenz, Alexandra Bernshausen, Heike Schneider, et al.. (2011). Selective Attenuation of Norepinephrine Release and Stress-Induced Heart Rate Increase by Partial Adenosine A1 Agonism. PLoS ONE. 6(3). e18048–e18048. 25 indexed citations
12.
Albrecht‐Küpper, Barbara, Kirsten Leineweber, & Peter G. Nell. (2011). Partial adenosine A1 receptor agonists for cardiovascular therapies. Purinergic Signalling. 8(S1). 91–99. 75 indexed citations
13.
Boor, Peter, Peter Celec, Ina V. Martin, et al.. (2011). The peroxisome proliferator-activated receptor-α agonist, BAY PP1, attenuates renal fibrosis in rats. Kidney International. 80(11). 1182–1197. 44 indexed citations
14.
Nell, Peter G. & Barbara Albrecht‐Küpper. (2009). 4 The Adenosine A1 Receptor and its Ligands. Progress in medicinal chemistry. 47. 163–201. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026